Shareholders Approved Name Change at January 6, 2026 Annual General Meeting as Company Evolves Beyond Single-Asset FocusTEL ...
MRK is up over 32% in three months, but declining estimates, Keytruda's upcoming LOE and Gardasil declines keep the stock ...
As the FCC considers a transition to ATSC 3.0, broadcasters tout a low-cost converter box program and whole-home DVR.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...
Bagsværd, Denmark, 24 November 2025 – Novo Nordisk today announced the top-line results from the 2-year primary analysis of evoke and evoke+ phase 3 trials in early-stage symptomatic Alzheimer’s ...
After years of technical analysis, public input and federal review, the Santa Clara Valley Transportation Authority (VTA) recently selected the single-bore tunnel as the preferred design method for ...
Edesa Biotech has shared data from its truncated phase 3 respiratory failure trial, linking the anti-TLR4 antibody to improvements in survival and recovery. The trial enrolled about 100 people who ...
Roche dived into the metabolic dysfunction-associated steatohepatitis (MASH) space by agreeing to hand over up to $3.5 billion for 89bio and its phase-3-stage candidate for the fatty liver disease. At ...
TI’s TPLD801 is a low-cost, eight-pin programmable logic device that integrates digital building blocks such as flip-flops, counters, delays, logic gates and pipe delay. When paralleling two or more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback